Investor Relations

SEC Filings

Document Details

Form
Filing Date
Mar 25, 2024
Document Date
Mar 25, 2024
Form Description
Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3
Filing Group
Registration Statements
Company
BioXcel Therapeutics
Issuer
BioXcel Therapeutics, Inc.